Meropenem

CAS 96036-03-2 5 current records 8 historicalSmall Molecule

Who holds supplier records for Meropenem? 5 organisations hold a current record for Meropenem: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability (5 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (2), Italy (1) and China (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Meropenem: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/meropenem

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Meropenem. Country is the organisation's recorded country, not necessarily the manufacturing site.

India2Italy1China1Country not recorded for 1
  • ACS DOBFAR SPA
    Active DMF 30488, 30489 · latest filing Jul 2016
    ItalyCEP Company GMP cert on record
  • SHENZHEN HAIBIN PHARMACEUTICAL CO LTD
    Active DMF 23524, 37927 · latest filing Mar 2023
    CEP Company GMP cert on record
  • UNIMARK REMEDIES LTD
    Active DMF 28279 · latest filing Jun 2014
    India
  • Shandong Anhong Pharmaceutical Co., Ltd.
    ChinaCEP Company GMP cert on record
  • IndiaCEP Company GMP cert on record
Need Meropenem sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Meropenem, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ACS DOBFAR S.P.A. TribianoIT
CEP 2011-238 - Rev 03
Meropenem trihydrate, Sterile, milled, synthetic origin, for parenteral preparations
Jun 2026—
SHANDONG ANHONG PHARMACEUTICAL CO., LTD. DezhouCN
CEP 2020-020 - Rev 02
Meropenem trihydrate, Sterile, synthetic origin, process I
Jan 2026Inspected Nov 2025
Greece
SHENZHEN HAIBIN PHARMACEUTICAL CO., LTD. Shenzhen CityCN
CEP 2024-097 - Rev 02
Meropenem trihydrate, Synthetic origin, Sterile, Process II
Jan 2026Inspected Feb 2025
Germany
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2018-268 - Rev 02
Meropenem trihydrate, Sterile, synthetic origin, process II
Oct 2025—
SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou CityCN
R1-CEP 2015-362 - Rev 00
Meropenem trihydrate, Sterile and synthetic origin
Oct 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Meropenem are no longer active. These show a past filing, not current supply.

Show all 8 historical records

Overview

Meropenem is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL127).

Chemical identity

IUPAC name
(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Canonical SMILES
C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O
InChIKey
DMJNNHOOLUXYBV-PQTSNVLCSA-N
Synonyms
ICI 194,660, ICI-194660, Meronem, Meropenem, Meropenem anhydrous, Meropenem, anhydrous, Meropenem (as trihydrate), Meropenem component of vabomere, Meropenem hydrate, Meropenem trihydrate, Merrem, Merrem i.v.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Penem Antibacterial
Chemical structure
Carbapenems

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Meropenem?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Meropenem: ACS DOBFAR SPA (Italy), SHENZHEN HAIBIN PHARMACEUTICAL CO LTD, UNIMARK REMEDIES LTD (India), Shandong Anhong Pharmaceutical Co., Ltd. (China) and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Meropenem Drug Master Files are active?

ACS DOBFAR SPA (DMF 30488, 30489), SHENZHEN HAIBIN PHARMACEUTICAL CO LTD (DMF 23524, 37927) and UNIMARK REMEDIES LTD (DMF 28279). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Meropenem records mean?

8 organisations have only inactive Type II DMFs for Meropenem. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Meropenem have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Meropenem on the EDQM register, including ACS DOBFAR S.P.A. Tribiano (IT), SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou (CN), SHENZHEN HAIBIN PHARMACEUTICAL CO., LTD. Shenzhen City (CN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN) and SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou City (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Meropenem supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Meropenem?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.